312 related articles for article (PubMed ID: 25256236)
1. Targeting integrin and integrin signaling in treating thrombosis.
Estevez B; Shen B; Du X
Arterioscler Thromb Vasc Biol; 2015 Jan; 35(1):24-9. PubMed ID: 25256236
[TBL] [Abstract][Full Text] [Related]
2. A Novel α
Kuo YJ; Chung CH; Pan TY; Chuang WJ; Huang TF
Toxins (Basel); 2019 Dec; 12(1):. PubMed ID: 31877725
[TBL] [Abstract][Full Text] [Related]
3. An α
Kuo YJ; Chen YR; Hsu CC; Peng HC; Huang TF
J Thromb Haemost; 2017 Nov; 15(11):2230-2244. PubMed ID: 28815933
[TBL] [Abstract][Full Text] [Related]
4. Platelet integrin αIIbβ3: signal transduction, regulation, and its therapeutic targeting.
Huang J; Li X; Shi X; Zhu M; Wang J; Huang S; Huang X; Wang H; Li L; Deng H; Zhou Y; Mao J; Long Z; Ma Z; Ye W; Pan J; Xi X; Jin J
J Hematol Oncol; 2019 Mar; 12(1):26. PubMed ID: 30845955
[TBL] [Abstract][Full Text] [Related]
5. Safety of glycoprotein IIb-IIIa inhibitors: A heart surgeon's perspective.
Dyke CM
Am Heart J; 1999 Oct; 138(4 Pt 2):307-16. PubMed ID: 10502236
[TBL] [Abstract][Full Text] [Related]
6. Anti-Platelet Peptides Targeting αIIbβ3 Outside-In Signaling Pathway.
Wang J; Xu X
Curr Protein Pept Sci; 2023; 24(1):31-42. PubMed ID: 36380406
[TBL] [Abstract][Full Text] [Related]
7. Conformation-Specific Blockade of αIIbβ3 by a Non-RGD Peptide to Inhibit Platelet Activation without Causing Significant Bleeding and Thrombocytopenia.
Shen C; Liu M; Tian H; Li J; Xu R; Mwangi J; Lu Q; Hao X; Lai R
Thromb Haemost; 2020 Oct; 120(10):1432-1441. PubMed ID: 32717755
[TBL] [Abstract][Full Text] [Related]
8. RGD-ligand mimetic antagonists of integrin alphaIIbbeta3 paradoxically enhance GPVI-induced human platelet activation.
Jones ML; Harper MT; Aitken EW; Williams CM; Poole AW
J Thromb Haemost; 2010 Mar; 8(3):567-76. PubMed ID: 20002543
[TBL] [Abstract][Full Text] [Related]
9. Current and future antiplatelet therapies: emphasis on preserving haemostasis.
McFadyen JD; Schaff M; Peter K
Nat Rev Cardiol; 2018 Mar; 15(3):181-191. PubMed ID: 29297508
[TBL] [Abstract][Full Text] [Related]
10. The search for new antithrombotic mechanisms and therapies that may spare hemostasis.
Plow EF; Wang Y; Simon DI
Blood; 2018 Apr; 131(17):1899-1902. PubMed ID: 29467183
[TBL] [Abstract][Full Text] [Related]
11. Eptifibatide-induced thrombocytopenia and thrombosis in humans require FcgammaRIIa and the integrin beta3 cytoplasmic domain.
Gao C; Boylan B; Bougie D; Gill JC; Birenbaum J; Newman DK; Aster RH; Newman PJ
J Clin Invest; 2009 Mar; 119(3):504-11. PubMed ID: 19197137
[TBL] [Abstract][Full Text] [Related]
12. The Antithrombotic Agent Pterostilbene Interferes with Integrin α
Huang WC; Lin KC; Hsia CW; Hsia CH; Chen TY; Bhavan PS; Sheu JR; Hou SM
Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33807403
[TBL] [Abstract][Full Text] [Related]
13. A directional switch of integrin signalling and a new anti-thrombotic strategy.
Shen B; Zhao X; O'Brien KA; Stojanovic-Terpo A; Delaney MK; Kim K; Cho J; Lam SC; Du X
Nature; 2013 Nov; 503(7474):131-5. PubMed ID: 24162846
[TBL] [Abstract][Full Text] [Related]
14. [Anti-platelets without a bleeding risk: novel targets and strategies].
Schaff M; Gachet C; Mangin PH
Biol Aujourdhui; 2015; 209(3):211-28. PubMed ID: 26820829
[TBL] [Abstract][Full Text] [Related]
15. A Naphthalenic Derivative ND-1 Inhibits Thrombus Formation by Interfering the Binding of Fibrinogen to Integrin
Ding X; Liu TD; Xie ZL; Zhao Q; Cao Y; Liu XD; Wang CH; Gamariel RR; Ming X; Li ZY; Kong Y
Biomed Res Int; 2016; 2016():8587164. PubMed ID: 28097150
[TBL] [Abstract][Full Text] [Related]
16. Platelet Signaling and Disease: Targeted Therapy for Thrombosis and Other Related Diseases.
Yeung J; Li W; Holinstat M
Pharmacol Rev; 2018 Jul; 70(3):526-548. PubMed ID: 29925522
[TBL] [Abstract][Full Text] [Related]
17. Platelet glycoprotein IIb/IIIa antagonists: lessons learned from clinical trials and future directions.
Leclerc JR
Crit Care Med; 2002 May; 30(5 Suppl):S332-40. PubMed ID: 12004256
[TBL] [Abstract][Full Text] [Related]
18. Clinical challenges of platelet glycoprotein IIb/IIIa receptor inhibitor therapy: bleeding, reversal, thrombocytopenia, and retreatment.
Tcheng JE
Am Heart J; 2000 Feb; 139(2 Pt 2):S38-45. PubMed ID: 10650315
[TBL] [Abstract][Full Text] [Related]
19. Trowaglerix Venom Polypeptides As a Novel Antithrombotic Agent by Targeting Immunoglobulin-Like Domains of Glycoprotein VI in Platelet.
Chang CH; Chung CH; Tu YS; Tsai CC; Hsu CC; Peng HC; Tseng YJ; Huang TF
Arterioscler Thromb Vasc Biol; 2017 Jul; 37(7):1307-1314. PubMed ID: 28596377
[TBL] [Abstract][Full Text] [Related]
20. RXR Ligands Negatively Regulate Thrombosis and Hemostasis.
Unsworth AJ; Flora GD; Sasikumar P; Bye AP; Sage T; Kriek N; Crescente M; Gibbins JM
Arterioscler Thromb Vasc Biol; 2017 May; 37(5):812-822. PubMed ID: 28254816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
